A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes.
Giulia Ricci, Lucia Ruggiero, Liliana Vercelli...
https://pubmed.ncbi.nlm.nih.gov/27126453/Actively Recruiting
Led by University of Pavia · Updated on 2026-04-21
48
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are evaluating whether amino acid supplementation combined with a structured diet and exercise program can improve body composition and physical performance in adults with facioscapulohumeral muscular dystrophy FSHD. This rare muscle disease causes progressive weakness mainly in the face, shoulders, and upper body, leading to reduced strength, aerobic capacity, walking ability, and increased fatigue. The study also compares responses between people with FSHD and healthy individuals matched by age and sex. Participants with FSHD will undergo two 6-month treatment phases with a 3-month break in between, receiving either amino acid supplements or placebo in random order. Healthy volunteers will complete one 6-month phase receiving exercise and diet only. All participants follow a personalized diet and home-based exercise plan including aerobic and resistance training. The amino acid supplement is given twice daily under blinded conditions. Throughout the 15-month study period, researchers will assess body composition, muscle strength, aerobic fitness, walking performance, and daily physical activity using tools like handgrip strength tests, gait analysis, VO2 max measurement, and accelerometers. Safety is monitored mainly for minor injuries related to exercise. The study aims to measure changes in fat mass, lean mass, aerobic capacity, muscle strength, and walking ability from start to end of treatment.
CONDITIONS
Amino Acids and Exercise in FSHD
G
giuseppe D'Antona, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Pavia
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 15 months for participants with FSHD; 6 months for healthy controls
Participants with FSHD undergo two 6-month phases of amino acid supplementation and placebo, separated by a 3-month washout period, combined with a personalized diet and home-based exercise program. Healthy controls complete a single 6-month phase of diet and exercise. Assessments are conducted at baseline and at the end of each intervention phase.
Baseline visit and 2 follow-up visits for participants with FSHD; baseline and 1 follow-up visit for healthy controls
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Giulia Ricci, Lucia Ruggiero, Liliana Vercelli...
https://pubmed.ncbi.nlm.nih.gov/27126453/Kathryn A Vera, Mary McConville, Michael Kyba...
https://pubmed.ncbi.nlm.nih.gov/32903446/Roel De Ridder, Julien Lebleu, Tine Willems...
https://pubmed.ncbi.nlm.nih.gov/30747572/Stephen P Bird, Mitch Nienhuis, Brian Biagioli...
https://pubmed.ncbi.nlm.nih.gov/38931241/Oscar Crisafulli, Renato Baptista, Patrik Drid...
https://pubmed.ncbi.nlm.nih.gov/39807483/Landry-Cyrille Bankolé, Guillaume Y Millet, John Temesi...
https://pubmed.ncbi.nlm.nih.gov/27495097/David D Church, Katie R Hirsch, Sanghee Park...
https://pubmed.ncbi.nlm.nih.gov/33276485/Ralf Jäger, Chad M Kerksick, Bill I Campbell...
https://pubmed.ncbi.nlm.nih.gov/28642676/Christopher I Morse, Emma L Bostock, Harriet M Twiss...
https://pubmed.ncbi.nlm.nih.gov/29669172/Sushma Alphonsa, Ryan Wuebbles, Takako Jones...
https://pubmed.ncbi.nlm.nih.gov/35734417/University of Pavia
Lead Sponsor